Argabright ST, Visoki E, Moore TM, Ryan DT, DiDomenico GE, Njoroge WFM, Taylor JH, Guloksuz S, Gur RC, Gur RE, Benton TD, Barzilay R. Association between discrimination stress and suicidality in preadolescent children. Journal of the American Academy of Child and Adolescent Psychiatry. 2022 May;61(5):686-697. PMID: 34425231.
Argabright ST, Moore TM, Visoki E, DiDomenico GE, Taylor JH, Barzilay R. Association between racial/ethnic discrimination and pubertal development in early adolescence. Psychoneuroendocrinology. 2022 Jun;140:105727. PMID: 35344870.
Muhrer E, Moxam A, Dunn M, Rosen A, Taylor JH, Camacho P, Bowden C, Worsley D, Doupnik SK. Acute Medical Workup for New-Onset Psychosis in Children and Adolescents: A Retrospective Cohort. Journal of Hospital Medicine. 2022 Jul 13 [Online ahead of print]. PMID: 35822507.
Xavier RM, Calkins ME, Bassett DS, Moore TM, George WT, Taylor JH, Gur RE. Characterizing Youth-Caregiver Discrepancies in Psychopathology Symptoms in a US Community Sample. Issues in Mental Health Nursing. 2022 Jul 15 [Online ahead of print]. PMID: 35839118.
Taylor JH, Appel S, Eli M, Alexander-Bloch A, Maayan L, Gur RE, Bloch MH. Time to clinical response in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study. Journal of Child and Adolescent Psychopharmacology. 2021 Feb;31(1):46-52. PMID: 32633541.
Londono-Tobon A, Flores JM, Taylor JH, Johnson I, Landeros-Weisenberger A, Aboiralor O, Avila-Quintero VJ, Bloch MH. Racial implicit associations in psychiatric diagnosis, treatment, and compliance expectations. Academic Psychiatry. 2021 Feb;45(1):23-33. PMID: 33438155.
Dong F, Calkins ME, Compton P, Medoff-Cooper B, Barzilay R, Taylor JH, Moore TM, Gur RC, Gur RE, Hodgson NA. Association between traumatic stressful events and schizotypal symptoms among a community-based sample of adolescents: A 2-year longitudinal study. Schizophrenia Research. 2021 July;233:44-51. PMID: 34225026.
Avrahami M, Peskin M, Moore T, Drapisz A, Taylor J, Segal-Gavish H, Balan-Moshe L, Shachar I, Levy T, Weizman A, Barzilay R. Body mass index increase in preschoolers with heterogeneous psychiatric diagnoses treated with risperidone. Journal of Psychopharmacology. 2021 Sep;35(9):1134-1140. PMID: 33892604.
Tang SX, Seelaus K, Moore T, Taylor JH, Moog C, O’Connor D, Burkholder M, Kohler C, Grant P, Eliash D, Calkins ME, Gur RE, Gur RC. Theater Improvisation Training to Promote Social Cognition (TIPS): A novel recovery-oriented intervention for youths at clinical risk for psychosis. Early Intervention in Psychiatry. 2020 Apr;14:163-171. PMID: 31177635.
Taylor JH, Asabere N, Calkins ME, Moore TM, Tang SX, Xavier R, Merikangas AK, Wolf DH, Almasy L, Gur RC, Gur RE. Characteristics of youth with reported family history of psychosis spectrum symptoms in the Philadelphia Neurodevelopmental Cohort. Schizophrenia Research. 2020 Feb;216:104-110. PMID: 31883930.
Barzilay R, White LK, Moore TM, Calkins ME, Taylor JH, Patrick A, Huque ZM, Young JF, Ruparel K, Pine DS, Gur RC, Gur RE. Association of anxiety phenotypes with risk of depression and suicidal ideation in community youth. Depression and Anxiety. 2020 Sep;37(9):851-861. PMID: 32500960.
Taylor JH, Landeros-Weisenberger A, Coughlin CG, Mulqueen J, Johnson JA, Gabriel D, Reed MO, Jakubovski E, Bloch MH. Ketamine for social anxiety disorder: a randomized placebo-controlled crossover trial. Neuropsychopharmacology. 2018;43:325-333. PMID: 28849779. (Featured on Vice.com and several other media outlets)
Taylor JH, Lebowitz ER, Jakubovski E, Coughlin CG, Silverman WK, Bloch MH. Monotherapy insufficient in severe anxiety? Predictors and moderators in the Child/Adolescent Anxiety Multimodal Study. Journal of Clinical Child & Adolescent Psychology. 2018;47(2):266-281. PMID: 28956620. (Featured on NPR.org and selected as Brain and Behavior Research Foundation Top Ten Research Achievement of 2017).
Woods SW, Powers AR, Taylor JH, Davidson C, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Lack of diagnostic pluripotentiality in patients at clinical high risk for psychosis: Specificity of comorbidity persistence and search for pluripotential subgroups. Schizophrenia Bulletin. 2018;44(2):254-263. PMID: 29036402.
Taylor JH, Jakubovski E, Gabriel D, Bloch MH. Predictors and moderators of antipsychotic-related weight gain in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study. Journal of Child and Adolescent Psychopharmacology. 2018 Sep;28(7):474-484. PMID: 29920116.
Taylor JH, Xu Y, Li F, Shaw M, Dzuria J, Caprio S, Tamborlane W, Nowicka P, Savoye M. Psychosocial predictors and moderators of weight management programme outcomes in ethnically-diverse obese youth. Pediatric Obesity. 2017;12:431-510. PMID: 27384496.
Gabriel D, Jakubovski E, Taylor JH, Artukoglu BB, Bloch MH. Predictors of treatment response and drop out in the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) study. Psychiatry Research. 2017;255:248-255. PMID: 28595147.
Taylor JH, Jakubovski E, Bloch MH. Predictors of anxiety recurrence in the Coordinated Anxiety Learning and Management (CALM) trial. Journal of Psychiatric Research. 2015;65:154-165. PMID: 25896121.
Taylor J, Belay B, Park S, Onufrak S, Dietz W. Association of church-sponsored activity participation and prevalence of overweight and obesity in African-American Protestants, National Survey of American Life, 2001-2003. Ethnicity & Disease. 2013;23(3):322-328. PMID: 23914418.
Yarlagadda A, Taylor JH, Hampe CS, Alfson E, Clayton AH. GAD65 antibodies, chronic psychosis, and type 2 diabetes mellitus. Innovations in Clinical Neuroscience. 2011;8:34-36. PMID: 21922068.
Goncharova EA, Lim PN, Chisolm A, Fogle HW, Taylor JH, Goncharov DA, Esterhas A, Panettieri RA, Krymskaya VP. Interferons modulate mitogen-induced protein synthesis in airway smooth muscle. American Journal of Physiology – Lung Cellular and Molecular Physiology. 2010;299(1):L25-35. PMID: 20382746.
Saunders D, Martin A, Taylor JH. “Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety: CAMS.” 50 Studies Every Psychiatrist Should Know. Oxford University Press. 2018.
Taylor JH, Lebowitz ER, Silverman WK. “Anxiety Disorders.” Lewis’s Child and Adolescent Psychiatry: A Comprehensive Textbook, 5th Edition. Philadelphia, PA: Wolters Kluwer. (pp. 509-518). 2017.
Posters and Presentations
Taylor JH. National Institute of Mental Health (NIMH), the Office of the Director and the Office for Disparities Research and Workforce Diversity. Listening session panelist. “Racial and ethnic NIMH funding disparities and underrepresentation in medicine and science.” Virtual, National Institutes of Health (Bethesda, MD). January 21, 2022.
Taylor JH. Geisinger Health System, Department of Psychiatry and Behavioral Health, Grand Rounds. “Treating psychotic disorders in children and adolescents now and in the future.” Hosted by: Jessica Goldhirsh, MD. Virtual, Geisinger Health (Danville, PA). March 10, 2022.
Taylor JH. American Academy of Child and Adolescent Psychiatry, Career Development Forum. Panelist. “Research in child and adolescent mental health.” Virtual, national panel (USA). Video available at https://youtu.be/MJq-KonbAfY August 1, 2022.
Taylor JH. Lucien E. Blackwell Community Center. Panelist. “CHOP’s Center for Advanced Behavioral Healthcare: An Introduction to the Community.” Hosted by: Philadelphia Housing Authority. 761 N. 47th Street, Philadelphia, PA. August 25, 2022.
Taylor JH. University of Virginia, Black Alumni Association. Oral presentation. “COVID-19, the vaccine and implications for the Black community.” Virtual (Charlottesville, VA). Video available at https://vimeo.com/535987230 April 8, 2021.
Taylor JH. Middlesex Health. Psychiatry Grand Rounds. “Optimizing schizophrenia treatment in youth and the possibility of prevention.” Virtual (Middletown, CT). May 6, 2021.
Taylor JH. American Academy of Child and Adolescent Psychiatry, Annual Meeting. Symposium Chair. “Previews from the pipeline: A data blitz featuring early career investigators.” Virtual. October 29, 2021.
Taylor JH. Mid-Atlantic Neuroscience Diversity Scholars (MiNDS) program for undergraduate students. “Black and on the path to understanding schizophrenia.” Virtual, Temple University (Philadelphia, PA). November 18, 2021.
Taylor JH. American Academy of Child and Adolescent Psychiatry, Annual Meeting. Symposium Chair. “A data blitz featuring early career investigators.” Virtual. October 20, 2020.
Taylor JH. American College of Neuropsychopharmacology, Annual Meeting. Study group oral presentation. “Clinical high risk for psychosis: Where do we go next?” Virtual. December 7, 2020.
Awards and Honors
2019, Schizophrenia International Research Society, Travel Award
2018, American Society of Clinical Psychopharmacology Clinical Trials Workshop, Travel Award
2017, Brain & Behavior Research Foundation Top Ten Advancements and Breakthroughs in 2017 by Foundation Grantees
2017, American College of Neuropsychopharmacology, Travel Award
2016, Selected for the Career Development Institute for Psychiatry, University of Pittsburgh and Stanford University
2014, American Psychiatric Association - Substance Abuse and Mental Health Services Administration Minority Fellowship Program
2013, American Academy of Child and Adolescent Psychiatry, Travel Award
2008, Student National Medical Association Community Service Award, University of Virginia
2006, Barbara Jordan Scholar for Cultural Leadership, Rice University
2006, John P. McGovern Award for Most Outstanding Premedical Student, Rice University
2006, Elected to Phi Beta Kappa Honor Society, Rice University
2006, Elected to Phi Lambda Upsilon National Chemistry Honor Society, Rice University
2006, Summa cum laude, Rice University
Leadership and Memberships
Memberships in Professional Organizations
2019-present, Schizophrenia International Research Society
2017-present, National Alliance on Mental Illness
2011-present, American Academy of Child and Adolescent Psychiatry
- 2020-present, Annual Meeting Program Committee Member
- 2011-present, Black Caucus Member
2010-present, American Psychiatric Association
- 2010-present, Black Caucus Member
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.